Aardvark Therapeutics, Inc.

AARD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 23, 2026 8-K
8-K Oct 22, 2026 8-K
4 Oct 8, 2026 4
3 Oct 8, 2026 3
8-K Oct 8, 2026 8-K
4 Sep 11, 2026 4
144 Sep 11, 2026
144 Sep 10, 2026
4 Aug 21, 2026 4
4 Aug 21, 2026 4
4 Aug 21, 2026 4
4 Aug 21, 2026 4
8-K Aug 17, 2026 8-K
10-Q Aug 11, 2026 10-Q
8-K Aug 11, 2026 8-K
ARS Jul 10, 2026 ARS
DEF 14A Jul 10, 2026 DEF 14A
PRE 14A Jun 29, 2026 PRE 14A
8-K Jun 12, 2026 8-K
8-K May 14, 2026 8-K
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
EFFECT Apr 3, 2026
424B5 Apr 3, 2026 424B5
CORRESP Mar 30, 2026
← Newer Page 1 of 5 · 114 filings Older →